These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

625 related items for PubMed ID: 17344041

  • 1. The uPA receptor and the somatomedin B region of vitronectin direct the localization of uPA to focal adhesions in microvessel endothelial cells.
    Salasznyk RM, Zappala M, Zheng M, Yu L, Wilkins-Port C, McKeown-Longo PJ.
    Matrix Biol; 2007 Jun; 26(5):359-70. PubMed ID: 17344041
    [Abstract] [Full Text] [Related]

  • 2. Plasminogen activator inhibitor-1 regulates cell adhesion by binding to the somatomedin B domain of vitronectin.
    Deng G, Curriden SA, Hu G, Czekay RP, Loskutoff DJ.
    J Cell Physiol; 2001 Oct; 189(1):23-33. PubMed ID: 11573201
    [Abstract] [Full Text] [Related]

  • 3. The urokinase receptor is a major vitronectin-binding protein on endothelial cells.
    Kanse SM, Kost C, Wilhelm OG, Andreasen PA, Preissner KT.
    Exp Cell Res; 1996 May 01; 224(2):344-53. PubMed ID: 8612711
    [Abstract] [Full Text] [Related]

  • 4. Localization of urokinase type plasminogen activator to focal adhesions requires ligation of vitronectin integrin receptors.
    Wilcox-Adelman SA, Wilkins-Port CE, McKeown-Longo PJ.
    Cell Adhes Commun; 2000 May 01; 7(6):477-90. PubMed ID: 11051458
    [Abstract] [Full Text] [Related]

  • 5. Vitronectin binding to urokinase receptor in human breast cancer.
    Carriero MV, Del Vecchio S, Franco P, Potena MI, Chiaradonna F, Botti G, Stoppelli MP, Salvatore M.
    Clin Cancer Res; 1997 Aug 01; 3(8):1299-308. PubMed ID: 9815812
    [Abstract] [Full Text] [Related]

  • 6. Endostatin-induced modulation of plasminogen activation with concomitant loss of focal adhesions and actin stress fibers in cultured human endothelial cells.
    Wickström SA, Veikkola T, Rehn M, Pihlajaniemi T, Alitalo K, Keski-Oja J.
    Cancer Res; 2001 Sep 01; 61(17):6511-6. PubMed ID: 11522648
    [Abstract] [Full Text] [Related]

  • 7. Urokinase-type plasminogen activator receptors associate with beta1 and beta3 integrins of fibrosarcoma cells: dependence on extracellular matrix components.
    Xue W, Mizukami I, Todd RF, Petty HR.
    Cancer Res; 1997 May 01; 57(9):1682-9. PubMed ID: 9135008
    [Abstract] [Full Text] [Related]

  • 8. High-molecular-weight serum protein complexes differentially promote cell migration and the focal adhesion localization of the urokinase receptor in human glioma cells.
    Hedberg KK, Stauff C, Høyer-Hansen G, Rønne E, Griffith OH.
    Exp Cell Res; 2000 May 25; 257(1):67-81. PubMed ID: 10854055
    [Abstract] [Full Text] [Related]

  • 9. Structure, function and expression on blood and bone marrow cells of the urokinase-type plasminogen activator receptor, uPAR.
    Plesner T, Behrendt N, Ploug M.
    Stem Cells; 1997 May 25; 15(6):398-408. PubMed ID: 9402652
    [Abstract] [Full Text] [Related]

  • 10. Urokinase plasminogen activator receptor promotes macrophage infiltration into the vascular wall of ApoE deficient mice.
    Gu JM, Johns A, Morser J, Dole WP, Greaves DR, Deng GG.
    J Cell Physiol; 2005 Jul 25; 204(1):73-82. PubMed ID: 15573379
    [Abstract] [Full Text] [Related]

  • 11. Discrimination of different forms of the murine urokinase plasminogen activator receptor on the cell surface using monoclonal antibodies.
    Rasch MG, Pass J, Illemann M, Høyer-Hansen G, Lund IK.
    J Immunol Methods; 2008 Nov 30; 339(1):55-65. PubMed ID: 18761343
    [Abstract] [Full Text] [Related]

  • 12. Reciprocal regulation of urokinase receptor (CD87)-mediated cell adhesion by plasminogen activator inhibitor-1 and protease nexin-1.
    Kanse SM, Chavakis T, Al-Fakhri N, Hersemeyer K, Monard D, Preissner KT.
    J Cell Sci; 2004 Jan 26; 117(Pt 3):477-85. PubMed ID: 14679304
    [Abstract] [Full Text] [Related]

  • 13. Variability in the expression of urokinase receptor (CD87) mutants on cells: relevance to cell adhesion.
    Kanse SM, Chavakis T, Kuo A, Bdeir K, Cines DB, Preissner KT.
    Cell Biochem Funct; 2004 Jan 26; 22(4):257-64. PubMed ID: 15248186
    [Abstract] [Full Text] [Related]

  • 14. Disulfide bonding arrangements in active forms of the somatomedin B domain of human vitronectin.
    Kamikubo Y, De Guzman R, Kroon G, Curriden S, Neels JG, Churchill MJ, Dawson P, Ołdziej S, Jagielska A, Scheraga HA, Loskutoff DJ, Dyson HJ.
    Biochemistry; 2004 Jun 01; 43(21):6519-34. PubMed ID: 15157085
    [Abstract] [Full Text] [Related]

  • 15. Modulation of invasive properties of human glioblastoma cells stably expressing amino-terminal fragment of urokinase-type plasminogen activator.
    Mohanam S, Chandrasekar N, Yanamandra N, Khawar S, Mirza F, Dinh DH, Olivero WC, Rao JS.
    Oncogene; 2002 Nov 07; 21(51):7824-30. PubMed ID: 12420219
    [Abstract] [Full Text] [Related]

  • 16. Interleukin-1alpha enhances the aggressive behavior of pancreatic cancer cells by regulating the alpha6beta1-integrin and urokinase plasminogen activator receptor expression.
    Sawai H, Okada Y, Funahashi H, Matsuo Y, Takahashi H, Takeyama H, Manabe T.
    BMC Cell Biol; 2006 Feb 20; 7():8. PubMed ID: 16504015
    [Abstract] [Full Text] [Related]

  • 17. Activation of urokinase receptor by a novel interaction between the connecting peptide region of urokinase and alpha v beta 5 integrin.
    Franco P, Vocca I, Carriero MV, Alfano D, Cito L, Longanesi-Cattani I, Grieco P, Ossowski L, Stoppelli MP.
    J Cell Sci; 2006 Aug 15; 119(Pt 16):3424-34. PubMed ID: 16882693
    [Abstract] [Full Text] [Related]

  • 18. The urokinase-receptor (CD87) is expressed in cells of the megakaryoblastic lineage.
    Wohn KD, Kanse SM, Deutsch V, Schmidt T, Eldor A, Preissner KT.
    Thromb Haemost; 1997 Mar 15; 77(3):540-7. PubMed ID: 9066008
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of HIV replication by the plasminogen activator is dependent on vitronectin-mediated cell adhesion.
    Elia C, Cassol E, Sidenius N, Blasi F, Castagna A, Poli G, Alfano M.
    J Leukoc Biol; 2007 Nov 15; 82(5):1212-20. PubMed ID: 17704294
    [Abstract] [Full Text] [Related]

  • 20. Photoaffinity labeling of the human receptor for urokinase-type plasminogen activator using a decapeptide antagonist. Evidence for a composite ligand-binding site and a short interdomain separation.
    Ploug M, Ostergaard S, Hansen LB, Holm A, Danø K.
    Biochemistry; 1998 Mar 17; 37(11):3612-22. PubMed ID: 9521680
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.